Abstract
The pulmonary hypertension of cor pulmonale can be reversed by sustained correction of hypoxia but continuous oxygen treatment poses problems in clinical practice. Alternative methods of relieving pulmonary vasoconstriction have therefore been explored. Eight patients with chronic cor pulmonale (five of them men) were studied to measure the haemodynamic effects of the calcium antagonist nifedipine, both at rest and on maximal, symptom limited exercise. The mean duration of exercise was unchanged by nifedipine (7.8 (SD 3.3) compared with 7.3(3.1) min). Cardiac output rose from 5.2(1.5) l min-1 to 8.6(3.3) 1 min-1 on exercise. Nifedipine increased resting cardiac output by 26%, but did not influence maximal exercise output. It did not significantly alter resting mean pulmonary artery pressure but reduced the level during exercise from 67(15) to 52(11) mm Hg. Nifedipine lowered resting pulmonary vascular resistance (PVR) by 32% and exercise PVR by 28%. It reduced supine mean systemic arterial pressure by 17%, standing pressure by 22%, and pressure at the maximal exercise level by 20%. Nifedipine lowered supine systemic vascular resistance (SVR) by 35%, standing SVR by 28%, and exercise SVR by 20%. Haemodynamic changes were achieved without adverse symptoms, alteration in arterial PO2, or impairment of calculated oxygen delivery. Nifedipine therefore reduced both pulmonary and systemic vasomotor tone at rest and during exercise. It did not alter exercise tolerance, which is probably limited by underlying respiratory disease. It seems possible therefore that nifedipine could delay the development of cor pulmonale, although this hypothesis remains to be tested.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Brent B. N., Mahler D., Berger H. J., Matthay R. A., Pytlik L., Zaret B. L. Augmentation of right ventricular performance in chronic obstructive pulmonary disease by terbutaline: a combined radionuclide and hemodynamic study. Am J Cardiol. 1982 Aug;50(2):313–319. doi: 10.1016/0002-9149(82)90182-5. [DOI] [PubMed] [Google Scholar]
- Davies C. T., Tuxworth W., Young J. M. Physiological effects of repeated exercise. Clin Sci. 1970 Aug;39(2):247–258. doi: 10.1042/cs0390247. [DOI] [PubMed] [Google Scholar]
- Kay J. M. Effect of intermittent normoxia on chronic hypoxic pulmonary hypertension, right ventricular hypertrophy, and polycythemia in rats. Am Rev Respir Dis. 1980 Jun;121(6):993–1001. doi: 10.1164/arrd.1980.121.6.993. [DOI] [PubMed] [Google Scholar]
- Kennedy T. P., Michael J. R., Huang C. K., Kallman C. H., Zahka K., Schlott W., Summer W. Nifedipine inhibits hypoxic pulmonary vasoconstriction during rest and exercise in patients with chronic obstructive pulmonary disease. A controlled double-blind study. Am Rev Respir Dis. 1984 Apr;129(4):544–551. [PubMed] [Google Scholar]
- Sturani C., Bassein L., Schiavina M., Gunella G. Oral nifedipine in chronic cor pulmonale secondary to severe chronic obstructive pulmonary disease (COPD). Chest. 1983 Aug;84(2):135–142. doi: 10.1378/chest.84.2.135. [DOI] [PubMed] [Google Scholar]
- Tiefenbrunn A. J., Biello D. R., Geltman E. M., Sobel B. E., Siegel B. A., Roberts R. Gated cardiac blood pool imaging and thallium-201 myocardial scintigraphy for detection of remote myocardial infarction. Am J Cardiol. 1981 Jan;47(1):1–6. doi: 10.1016/0002-9149(81)90281-2. [DOI] [PubMed] [Google Scholar]